Fate of MHC-matched corneal allografts in Th1-deficient hosts

被引:44
作者
Hargrave, SL [1 ]
Hay, C [1 ]
Mellon, J [1 ]
Mayhew, E [1 ]
Niederkorn, JY [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA
关键词
D O I
10.1167/iovs.03-0515
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
PURPOSE. To determine whether the Th1 cytokine, interferon (IFN)-gamma, is necessary for corneal graft rejection. METHODS. Full-thickness penetrating keratoplasties were performed in normal mice and in IFN-gamma knockout (KO) mice. RESULTS. Sixty-four percent of the MHC-mismatched corneal allografts were rejected in IFN-gamma KO mice. By contrast, MHC-matched corneal allografts were rejected in 50% to 77% of the wild-type hosts, but were not rejected in any of the IFN-gamma KO mice or the wild-type mice treated with anti-IFN-gamma monoclonal antibody. Corneal graft rejection in IFN-gamma- deficient hosts was characterized by an eosinophilic infiltrate compared with a mononuclear inflammatory infiltrate in normal mice. CONCLUSIONS. IFN-gamma is not necessary for the rejection of MHC-mismatched corneal grafts. However, IFN-gamma and Th1 immune mechanisms are necessary for the rejection of MHC-matched corneal allografts that confront the host with foreign minor histocompatibility antigens. The immune response in atopic patients, as in IFN-gamma KO mice, is characterized by cross-regulation of Th1 cytokines, such as IFN-gamma. The present results indicate that MHC matching dramatically reduces the risk of corneal graft rejection when IFN-gamma is depressed or absent. Thus, MHC matching may reduce the risk of corneal graft rejection in patients with atopic keratoconus.
引用
收藏
页码:1188 / 1193
页数:6
相关论文
共 31 条
[1]
PROLONGATION OF RAT CORNEAL GRAFT-SURVIVAL BY TREATMENT WITH ANTI-CD4 MONOCLONAL-ANTIBODY [J].
AYLIFFE, W ;
ALAM, Y ;
BELL, EB ;
MCLEOD, D ;
HUTCHINSON, IV .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1992, 76 (10) :602-606
[2]
BATCHELOR JR, 1976, LANCET, V1, P551
[3]
Immunobiology of allograft rejection in the absence of IFN-γ:: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions [J].
Bishop, DK ;
Wood, SC ;
Eichwald, EJ ;
Orosz, CG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3248-3255
[4]
CALLANAN DG, 1989, INVEST OPHTH VIS SCI, V30, P413
[5]
Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis [J].
Echtenacher, B ;
Freudenberg, MA ;
Jack, RS ;
Männel, DN .
INFECTION AND IMMUNITY, 2001, 69 (12) :7271-7276
[6]
THE BIOLOGY OF THE EOSINOPHILIC LEUKOCYTE [J].
GLEICH, GJ ;
ADOLPHSON, CR ;
LEIFERMAN, KM .
ANNUAL REVIEW OF MEDICINE, 1993, 44 :85-101
[7]
Organogenic role of B lymphocytes in mucosal immunity [J].
Golovkina, TV ;
Shlomchik, M ;
Hannum, L ;
Chervonsky, A .
SCIENCE, 1999, 286 (5446) :1965-1968
[8]
Preliminary findings in corneal allograft rejection in patients with keratoconus [J].
Hargrave, S ;
Chu, YL ;
Mendelblatt, D ;
Mayhew, E ;
Niederkorn, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (04) :452-460
[9]
He YG, 1996, CORNEA, V15, P82
[10]
HE YG, 1991, INVEST OPHTH VIS SCI, V32, P2723